What Researchers Did
Researchers conducted a review of osteoradionecrosis (ORN) of the jaw, its causes, complications, and treatment options, with a focus on combined therapy using pentoxifylline and tocopherol.
What They Found
The review found that osteoradionecrosis (ORN) of the jaw is a significant complication of radiotherapy for oral cavity cancer, with various treatment options available. It discussed the definition, classifications, etiology, and pathophysiology of ORN, and explored treatments including hyperbaric oxygen therapy, surgical approaches, and combined therapy with pentoxifylline and tocopherol.
What This Means for Canadian Patients
Canadian patients undergoing radiotherapy for oral cavity cancer may benefit from understanding the various treatment options for osteoradionecrosis (ORN) of the jaw. This review highlights the potential of combined therapy with pentoxifylline and tocopherol as a treatment approach for this challenging condition.
Canadian Relevance
This study has no specific Canadian connection.
Study Limitations
As a review article, this study synthesizes existing literature and does not present new primary research data or clinical trial results.